Loading
Latest filing published 25 Aug 2026 for Theralase Technologies Inc., €665. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Matthew Thomas Perraton is a declared insider of Theralase Technologies Inc., with filings sourced from SEDI. Between 7 August 2026 and 24 August 2026, the trades on record add up to 3 filings.
Not one of the filings records a straightforward purchase or sale on the market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
On 25 August 2026 came the latest disclosure, a transaction for €665 in Theralase Technologies Inc. Typically, a trade is published a median of 1 day after it takes place. This delay matters because a trade only becomes useful information once it is public. Source: insider filings from SEDI. Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations